Pharma-Bio Serv (PBSV) Current Assets (2010 - 2026)

Pharma-Bio Serv's Current Assets history runs 16 years deep, the most recent figure standing at $11.3 million for Q2 2026.

• Quarterly Current Assets fell 15.88% year-over-year to $11.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $11.3 million (down 15.88% YoY) and the FY2025 annual result came in at $13.4 million, down 14.73% from the prior year.
• Current Assets was $11.3 million for Q2 2026 at Pharma-Bio Serv, down from $13.3 million in the prior quarter.
• Across five years, Current Assets topped out at $21.0 million in Q1 2022 and bottomed at $11.3 million in Q2 2026.
• A 5-year average of $16.9 million and a median of $17.6 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets slipped 28.52% — and 2023, when it grew 0.75%.
• Pharma-Bio Serv's Current Assets stood at $19.9 million in 2022, then decreased by 2.72% to $19.4 million in 2023, then decreased by 19.08% to $15.7 million in 2024, then retreated by 14.73% to $13.4 million in 2025, then declined by 15.69% to $11.3 million in 2026.
• Business Quant data shows PBSV's Current Assets at $11.3 million in Q2 2026, $13.3 million in Q1 2026, and $13.4 million in Q4 2025.